In 1990, instruction of diabetic patients was not recognised by health insu
rance providers in Germany, and a practitioner received no remuneration for
training patients. Moreover, no physicians specialised in diabetology were
recognised by health insurance providers. Specialised diabetology was perf
ormed exclusively in hospitals. Physicians conducting their practice in off
ices and intersted in caring for diabetic patients were in a rather difficu
lt situation. In 1991, remuneration was provided for the first time in Germ
any for therapeutic training of Type 2 (non-insulin-dependent) diabetic pat
ients. Health insurance providers paid physicians DM 60 per patient for 4 c
lass sessions. Since 1993, physicians in the Brandenburg region have been r
eceiving DM 250 per patient for 5 class sessions (thus DM 1,000 for a group
of 4 patients) to provide therapeutic training for Type 2 diabetic patient
s on conventional insulin therapy This programme has been assessed in two r
eported studies: one showing that this ambulatory programme is as efficient
as training in a hospital and the other evaluating the setting up of the B
randenburg programme. However,the number of patients receiving training in
medical offices has remained inadequate (around 250,000 patients in total).
In 1997/98, in order to improve this situation, a health insurance group,
the VdAK/AEV (representing nearly half of the insured persons in Germany),
raised fees for physicians from DM 60 to 200 per patient for the training o
f diabetic patients. Moreover a book for patients (the "passport for diabet
ic persons" provided by the German Association of Diabetology) is distribut
ed to patients during the training courses and reimbursed by the insurers.
Within a few years in nearly all regions of Germany, diabetologists practis
ing in medical offices have succeeded in obtaining special contracts for pe
rformance of ambulatory diabetology. This development began in East Germany
but has now spread to most regions of West Germany. In 1998, an annual exa
mination for diabetic patients was established for preventive purposes. Thu
s, remuneration is related to precise disease documentation (feet, nephropa
thy, retinopathy). This model is currently being evaluated in Wolfsburg for
all diabetic patients covered by the insurers of Volkswagen AG. The first
results expected in 1999 will be useful in extending this preventive examin
ation to other regions of Germany.